» Articles » PMID: 22851862

ERCP for the Treatment of Bile Leak After Partial Hepatectomy and Fenestration for Symptomatic Polycystic Liver Disease

Overview
Specialty Gastroenterology
Date 2012 Aug 2
PMID 22851862
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To describe endoscopic treatment of bile leaks in these patients and to identify risk factors in these patients which can predict the development of bile leaks.

Methods: Retrospective case-control study examining consecutive patients who underwent partial hepatectomy for polycystic liver disease (PLD) and developed a postoperative bile leak managed endoscopically over a ten year period. Each case was matched with two controls with PLD who did not develop a postoperative bile leak.

Results: Ten cases underwent partial hepatectomy with fenestration for symptoms including abdominal distention, pain and nausea. Endoscopic retrograde cholangiopancreatography (ERCP) showed anatomic abnormalities in 1 case. A biliary sphincterotomy was performed in 4 cases. A plastic biliary stent was placed with the proximal end at the site of the leak in 9 cases; in 1 case two stents were placed. The overall success rate of ERCP to manage the leak was 90%. There were no significant differences in age, gender, comorbidities, duration of symptoms, history of previous surgery or type of surgery performed between cases and controls.

Conclusion: ERCP with stent placement is safe and effective for management of post-hepatectomy bile leak in patients with PLD.

Citing Articles

Prevention of bile duct injury using indocyanine green fluorescence in laparoscopic liver cyst fenestration for giant liver cyst: a case report.

Shimagaki T, Itoh S, Toshida K, Tomiyama T, Morinaga A, Kosai Y J Surg Case Rep. 2022; 2022(10):rjac479.

PMID: 36285169 PMC: 9581503. DOI: 10.1093/jscr/rjac479.


Avoidance of bile duct injury during laparoscopic liver cyst fenestration using indocyanine green: A case report.

Hanaki T, Yagyu T, Uchinaka E, Morimoto M, Watanabe J, Tokuyasu N Clin Case Rep. 2020; 8(8):1419-1424.

PMID: 32884766 PMC: 7455442. DOI: 10.1002/ccr3.2840.


Laparoscopic deroofing for polycystic liver disease using laparoscopic fusion indocyanine green fluorescence imaging.

Tanaka M, Inoue Y, Mise Y, Ishizawa T, Arita J, Takahashi Y Surg Endosc. 2015; 30(6):2620-3.

PMID: 26416378 DOI: 10.1007/s00464-015-4526-x.


Diagnosis and management of polycystic liver disease.

Gevers T, Drenth J Nat Rev Gastroenterol Hepatol. 2013; 10(2):101-8.

PMID: 23296249 DOI: 10.1038/nrgastro.2012.254.

References
1.
Nuttall M, van der Meulen J, Emberton M . Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol. 2006; 59(3):265-73. DOI: 10.1016/j.jclinepi.2005.07.015. View

2.
Everson G, Taylor M, Brian Doctor R . Polycystic disease of the liver. Hepatology. 2004; 40(4):774-82. DOI: 10.1002/hep.20431. View

3.
Torres V . Treatment of polycystic liver disease: one size does not fit all. Am J Kidney Dis. 2007; 49(6):725-8. DOI: 10.1053/j.ajkd.2007.04.009. View

4.
Coelho-Prabhu N, Baron T . Assessment of need for repeat ERCP during biliary stent removal after clinical resolution of postcholecystectomy bile leak. Am J Gastroenterol. 2009; 105(1):100-5. DOI: 10.1038/ajg.2009.546. View

5.
Schnelldorfer T, Torres V, Zakaria S, Rosen C, Nagorney D . Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation. Ann Surg. 2009; 250(1):112-8. DOI: 10.1097/SLA.0b013e3181ad83dc. View